The accurate hemodynamic assessment of patients with congenital heart disease is a fundamental part of the work of the cardiac catheterization laboratory. The direct Fick principle remains the gold standard for calculation of hemodynamic indices in which oxygen consumption (V[o]{.smallcaps}~2~) must be known.[@bib1] Although techniques for metabolic monitoring using indirect calorimetry or respiratory mass spectrometry are available for the measurement of V[o]{.smallcaps}~2~,[@bib2; @bib3; @bib4] it is still common practice to estimate V[o]{.smallcaps}~2~ values from tables or published predictive equations. Considerable errors introduced by using assumed V[o]{.smallcaps}~2~ have been reported.[@bib5; @bib6; @bib7; @bib8] We have previously examined the validity of 4 equations in estimating V[o]{.smallcaps}~2~ by comparison with directly measured V[o]{.smallcaps}~2~ by respiratory mass spectrometry and found poor agreement in all.[@bib8] Among these, the LaFarge equation,[@bib9] the most commonly used equation, gave the closest estimation with the least bias and limits of agreement. However, our previous study excluded patients whose ages fell outside the range originally used to generate the LaFarge equation, that is, younger than 3 years. Despite the LaFarge equation was restricted to patients between 3 and 40 years of age, it is applied in patients of all ages undergoing cardiac catheterization. With advances in surgical techniques and perioperative management, increasing numbers of patients with complex congenital heart defects undergo cardiac surgery at a younger age. This has resulted in an increasing need for diagnostic cardiac catheterization in children younger than 3 years, often with the single goal of accurate evaluation of systemic and pulmonary blood flows and vascular resistances, particularly pulmonary vascular resistance.

If V[o]{.smallcaps}~2~ needs to be measured at all, then accuracy is vital.[@bib10; @bib11] A discrepancy between estimated and measured V[o]{.smallcaps}~2~ will translate directly into an equivalent percentage underestimation or overestimation of blood flow and vascular resistance. Any error in hemodynamic assessment may significantly mislead surgical and other clinical treatment strategies. Therefore, we revisited our previous data to examine the validity of the LaFarge equation with emphasis on children less than 3 years of age with congenital heart disease undergoing cardiac catheterization.

Methods
=======

A total of 75 patients with congenital heart disease (age range 0.13-24 years) were studied under general anesthesia during cardiac catheterization in the period between 1996 and 2001. These patients all underwent hemodynamic monitoring with V[o]{.smallcaps}~2~ measurement for other clinical studies approved by the ethics committee of the Royal Brompton Hospital or Great Ormond Street Hospital, London, United Kingdom,[@bib12; @bib13; @bib14; @bib15] and conform to the Declaration of Helsinki. The original clinical studies investigated pharmacologic and ventilatory interventions on cardiac output and pulmonary vascular resistance in children with various congenital heart defects before and after surgical repair.[@bib12; @bib13; @bib14; @bib15] The V[o]{.smallcaps}~2~ measurements were performed at baseline, before any intervention and are used in the present study. Patients were divided into 2 groups according to age \<3 years (n = 40) or ≥≥3 years (n = 35). Patient diagnoses and demographics in the 2 groups are shown in [Table I](#tbl1){ref-type="table"}.

The technique to measure V[o]{.smallcaps}~2~ was described in our previous report.[@bib16] Briefly, all patients were sedated and paralyzed with continuous intravenous infusions of propofol and vecuronium. Patients were intubated with a cuffed endotracheal tube (Mallinckrodt Medical, Northampton, United Kingdom) to rule out any respiratory gas leaks. An Amis 2000 quadrupole respiratory mass spectrometer (Innovision A/S, Odense, Denmark) was adapted for use in ventilated patients as described elsewhere.[@bib16; @bib17] V[o]{.smallcaps}~2~ was measured continuously using the mixed expirate argon dilution method that allows the mass spectrometer alone to measure metabolic gas exchange and ventilation volume.[@bib1] This requires analysis of inspired and expired gases, together with the collection of all expired gas. This is a sensitive and accurate method for continuous gas analysis that allows simultaneous measurements of multiple gas fractions within a mixture.[@bib2]^,^[@bib18; @bib19; @bib20]

The estimated V[o]{.smallcaps}~2~ values were calculated from the equation published by LaFarge[@bib2] for the entire group of patients of all ages as follows:$$\text{males:}\text{VO}_{2}\text{(mL/min/m}^{2}\text{)} = 138.1 - \left( 11.49 \times \log_{e}\text{age} \right) + \left( 0.378 \times \text{HR} \right)\text{and}$$$$\text{females:}\text{VO}_{2}\left( \text{mL/min/m}^{2} \right) = 138.1 - \left( 17.04 \times \log_{e}\text{age} \right) + \left( 0.378 \times \text{HR} \right)\text{,}$$where age is in years and HR indicates heart rate in beats/min.

Statistical analysis
--------------------

The agreement between estimated and measured V[o]{.smallcaps}~2~ was analyzed using the method of Bland and Altman[@bib21] for comparison of 2 methods estimating the same quantity. The bias is the mean of the difference of measured minus estimated V[o]{.smallcaps}~2~ values; this represents the systematic error. Limits of agreement are the bias ± 2 SD; this represents the random error. The method was applied to the group as a whole and then separately to the group of \<3 years and the group ≥≥3 years. A bias of near zero indicates close agreement, as would narrow limits of agreement. The difference between estimated and measured V[o]{.smallcaps}~2~ was also expressed as percentage of the measured V[o]{.smallcaps}~2~. Unpaired *t* test was used to compare the absolute and percentage differences between the 2 groups. Regression analysis was used to evaluate the influence of age on the values of estimated V[o]{.smallcaps}~2~, measured V[o]{.smallcaps}~2~, and the differences between estimated and measured V[o]{.smallcaps}~2~. Parameter estimate indicates the slope of change of V[o]{.smallcaps}~2~ values per year of age. A *P* value \< .05 was considered significant.
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Results
=======

For the entire group, V[o]{.smallcaps}~2~ was overestimated by the LaFarge equation, with a bias of 33 mL/kg/m^2^, that is, by 33%. The limits of agreement were widely spread from −56 to +123 mL/kg per square meter. Further analysis was performed in the 2 groups of patients of \<3 and ≥≥3 years. Estimation was significantly poorer in the group \<3 years with a bias of 55 mL/kg per square meter, as compared to the older group with a bias of 11 mL/kg per square meter. The limits of agreements were −42 to +153 mL/kg/m^2^ for children \<3 years versus −39 to +61 mL/kg/m^2^ for those ≥3 years ([Figure 1](#fig1){ref-type="fig"}, *A* and *B*).

Further analyses were performed to examine the trends of estimated and measured V[o]{.smallcaps}~2~ in relation to age. Estimated V[o]{.smallcaps}~2~, as presented in the LaFarge equation itself, used a logarithmic transformation of age (parameter estimate = −20, *P* \< .0001), whereby there was a rapid decrease from age 0 to 3 years, followed by a slower decrease thereafter ([Figure 2](#fig2){ref-type="fig"}A). Measured V[o]{.smallcaps}~2~, on the other hand, followed a polynomial trend in relation to age; there was a rapid increase in about the first 3 to 4 years (parameter estimate = 12.7, *P* = .002) followed by a small decrease until approximately age 16 (parameter estimate = −1.63, *P* = .001) and a smaller increase thereafter (parameter estimate = .044, *P* = .002) ([Figure 2](#fig2){ref-type="fig"}, *B*). As a result, the difference between estimated and measured V[o]{.smallcaps}~2~, as expressed by both the absolute value and percentage of measured V[o]{.smallcaps}~2~, showed a logarithmic trend with a rapid decrease from age 0 to 3 years, followed by a small decrease thereafter (parameter estimate = −22, *P* \< .0001 for the absolute difference; parameter estimate = −21, *P* \< .0001 for the percentage difference) ([Figure 2](#fig2){ref-type="fig"}, *C* and *D*). The mean absolute and percentage difference was 55 ± 48 mL/min/m^2^ and 53% ± 52%, respectively, in children \<3 years old; they were 11 ± 25 mL/min/m^2^ and 11% ± 21%, respectively, in children ≥3 years (*P* \< .0001 for both).

Discussion
==========

We report that the LaFarge equation led to significantly poorer estimation of V[o]{.smallcaps}~2~ when applied to children younger than to 3 years with congenital heart defects undergoing cardiac catheterization, as compared to those older than 3 years, with a significantly wider range of limits of agreement and greater overestimation. We have shown that the LaFarge equation introduced an overestimation of V[o]{.smallcaps}~2~ in children younger than 3 years of 53%, as compared to 11% in the older group, as well as a greater random error in individual patients as indicated by the much poorer agreement in the younger group of children. The age effect is attributed by 2 factors; firstly, the logarithmic nature in the LaFarge equation, and secondly, by a markedly lower directly measured V[o]{.smallcaps}~2~ in the younger group.

The LaFarge equation was originally generated from a cohort of 879 patients who were mostly children, studied between 1961 and 1966.[@bib9] It was validated by the traditional Douglas Bag method to measure V[o]{.smallcaps}~2~. The past half century has seen significant progress in pediatric cardiology and cardiovascular surgery as well as technology to measure V[o]{.smallcaps}~2~. Although the LaFarge equation provides the closest estimation of V[o]{.smallcaps}~2~ among all the predictive equations[@bib8] and remains the most commonly used in cardiac laboratories, it has a number of limitations in clinical practice. One of the main factors contributing to the poor agreement between LaFarge\'s estimated V[o]{.smallcaps}~2~ and our directly measured V[o]{.smallcaps}~2~ is in the use of conscious sedation with spontaneous ventilation in LaFarge\'s study population, whereas we (and many others) use general anesthesia and mechanical ventilation during cardiac catheterization. The latter approach alone can reduce V[o]{.smallcaps}~2~ by up to 20% to 30%.[@bib22; @bib23; @bib24] In addition, the Douglas Bag method, used to generate the LaFarge equation, brings with it limitations including the lack of measurement of carbon dioxide concentrations in respiratory gases and an assumed respiratory quotient.[@bib9] A fixed respiratory quotient is not valid in cardiac patients with varied hemodynamics and unpredictable nutritional status.[@bib25] In our patients, V[o]{.smallcaps}~2~ was measured with consideration of carbon dioxide concentrations in the respiratory gases by respiratory mass spectrometry.

Most importantly, the derivation of the LaFarge equation was from patients aged between 3 and 40 years. Despite this fact, the equation is commonly applied to patients of all ages. Some studies have examined the impact of age on estimated V[o]{.smallcaps}~2~ by the LaFarge equation by excluding patients younger than 3 years[@bib7] or by comparing age groups of younger or older than 60 years.[@bib5] However, its validity has not been previously explored in children younger than 3 years. Looking closely into the LaFarge equation, the logarithmic transformation of age intrinsically results in a faster increase in V[o]{.smallcaps}~2~ as age decreases, particularly within the first 3 years of life, as shown clearly in our data ([Figure 2](#fig2){ref-type="fig"}, *A*). In our patients, the estimated V[o]{.smallcaps}~2~ was the highest in the youngest patient (0.13 years). Estimated V[o]{.smallcaps}~2~ then decreased in the first 3 years, followed by a small decrease at older ages. Interestingly, in our study, measured V[o]{.smallcaps}~2~ showed almost exactly the opposite trend and was the lowest in the youngest patients and then quickly increased in the first 3 or 4 years. A lower measured V[o]{.smallcaps}~2~ in children younger than 3 years has also been reported by others.[@bib26] The mechanism remains unclear but may be related to body composition---in particular "fat mass" that is higher in younger children[@bib27; @bib28] and V[o]{.smallcaps}~2~ in fat mass is about 20 times less than that in fat-free mass.[@bib28]

Errors in V[o]{.smallcaps}~2~ will result in errors of the same magnitude in the calculation of systemic and pulmonary blood flow and ultimately errors in calculations of systemic and pulmonary vascular resistances. The most consistent patient population undergoing diagnostic catheterization continues to be the single-ventricle patient where catheterization is performed to specifically evaluate the pulmonary artery architecture, pressure, and vascular resistance. Numerous investigators have shown that elevated pulmonary vascular resistance is a risk factor for poor outcome,[@bib29; @bib30; @bib31] emphasizing the need for accurate hemodynamic assessment. Although most patients can be risk stratified for Fontan completion fairly easily based on clinical, echocardiographic, magnetic resonance imaging, or catheterization criteria, it is the borderline patient in which accurate hemodynamic assessment is critical. Shanahan et al[@bib32] reported that all formulas used to estimate V[o]{.smallcaps}~2~ lead to underestimation of the true indexed pulmonary vascular resistance, to an extent that could significantly influence clinical decision making. This is supported by our data. A mean of 50% underestimation of pulmonary vascular resistance can be introduced when using LaFarge equation in children younger than 3 years old.

Limitations
-----------

Because of the designs of the original research projects, only one patient in the group of children younger than 3 years had a functional single ventricle undergoing the Fontan procedure. There may be some degree of difference in V[o]{.smallcaps}~2~ in patients with functional single-ventricle physiology as compared to those with a biventricular circulation due to differences in cardiovascular work and hemodynamic and metabolic status.[@bib33; @bib34; @bib35] Our data cannot therefore directly address this relationship, although any differences are unlikely to be significant enough to affect the information obtained from the current study.

Conclusion
==========

The LaFarge equation induces a significantly poorer estimation of V[o]{.smallcaps}~2~ when used in children younger than 3 years as compared to older patients, with greater overestimation and random errors in individual errors. Direct measurement of V[o]{.smallcaps}~2~ rather than its estimation is necessary in children with congenital heart disease undergoing cardiac catheterization, particularly in those younger than 3 years.
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###### 

Diagnoses in 2 groups of patients of ≤\<3 and ≥≥3 years old

  Diagnosis         No. of patients   
  ----------------- ----------------- ----
  AP window         0                 1
  ASD               5                 5
  ASD VSD           1                 0
  AVSD              12                2
  Cardiomyopathy    0                 1
  DORV, PAPVD       0                 1
  Fontan            1                 7
  MV disease        2                 2
  Mustard/senning   1                 2
  PDA               5                 5
  Pulmonary HT      0                 2
  ToF               2                 3
  VSD               12                4
  Total             40                35

*AP*, Aortopulmonary; *ASD*, atrial septal defect; *VSD*, ventricular septal defect; *AVSD*, atrioventricular septal defect; *DORV*, double outlet right ventricle; *PAPVD*, partial anomalous pulmonary venous drainage; *MV*, mitral valve; *PDA*, patent ductus arteriosus; *HT*, hypertension; *ToF*, tetralogy of Fallot.
